Correction to article on growth in 'branded generics'
October 23 2017 - 11:26AM
Dow Jones News
Todd Chermak is Abbott's head of innovation and development for
emerging markets. "Drug Makers Find 'Branded Generics' Are a Source
for Growth" at 8:10 ET, incorrectly spelled his surname as Chermark
in the 24th paragraph. (Oct. 23)
(END) Dow Jones Newswires
October 23, 2017 11:11 ET (15:11 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
Historical Stock Chart
From Dec 2024 to Jan 2025
Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
Historical Stock Chart
From Jan 2024 to Jan 2025
